Description

GenRx Tirzepatide is a long-acting synthetic peptide analog that functions as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Supplied as a 30mg lyophilized powder, Tirzepatide is designed for scientific and preclinical research exploring mechanisms related to metabolic regulation, insulin signaling, and glucose homeostasis.

Key Features:

• Molecular Formula: C₂₂₅H₃₄₈N₆₄O₆₈
• Molecular Weight: 4813.5 g/mol
• Form: Lyophilized (freeze-dried) powder
• Purity: ≥ 99% (by HPLC)
• Quantity: 30 mg per vial
• Storage: Store lyophilized at room temperature in a dry, dark environment. After reconstitution, refrigerate (2–8 °C) and use within a limited period.
• Packaging: Sealed 30 mg research-grade vial

Research Applications:
Tirzepatide is under active investigation for its effects on metabolic modulation, energy balance, and insulin sensitivity. Laboratory studies focus on its dual incretin activity and potential influence on glucose metabolism, body composition, and cellular energy pathways.

Intended Use:
For laboratory research purposes only. Not for human or animal use, injection, or diagnostic procedures. Researchers should follow standard sterile handling and laboratory safety protocols.